- Home
- BLBD vs TVTX Comparison
BLBD vs TVTX Comparison
Compare BLBD & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLBD
- TVTX
- Stock Information
- Founded
- BLBD 1927
- TVTX 2008
- Country
- BLBD United States
- TVTX United States
- Employees
- BLBD N/A
- TVTX N/A
- Industry
- BLBD Construction/Ag Equipment/Trucks
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- BLBD Consumer Discretionary
- TVTX Health Care
- Exchange
- BLBD Nasdaq
- TVTX Nasdaq
- Market Cap
- BLBD 1.3B
- TVTX 1.5B
- IPO Year
- BLBD N/A
- TVTX N/A
- Fundamental
- Price
- BLBD $56.40
- TVTX $18.23
- Analyst Decision
- BLBD Strong Buy
- TVTX Strong Buy
- Analyst Count
- BLBD 7
- TVTX 16
- Target Price
- BLBD $57.36
- TVTX $33.40
- AVG Volume (30 Days)
- BLBD 720.8K
- TVTX 1.4M
- Earning Date
- BLBD 08-06-2025
- TVTX 08-06-2025
- Dividend Yield
- BLBD N/A
- TVTX N/A
- EPS Growth
- BLBD 15.49
- TVTX N/A
- EPS
- BLBD 3.49
- TVTX N/A
- Revenue
- BLBD $1,420,946,000.00
- TVTX $333,865,000.00
- Revenue This Year
- BLBD $9.64
- TVTX $71.61
- Revenue Next Year
- BLBD $7.99
- TVTX $43.45
- P/E Ratio
- BLBD $16.19
- TVTX N/A
- Revenue Growth
- BLBD 9.31
- TVTX 87.94
- 52 Week Low
- BLBD $30.04
- TVTX $8.46
- 52 Week High
- BLBD $60.45
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- BLBD 77.12
- TVTX 71.24
- Support Level
- BLBD $42.95
- TVTX $15.60
- Resistance Level
- BLBD $57.23
- TVTX $17.46
- Average True Range (ATR)
- BLBD 2.07
- TVTX 0.80
- MACD
- BLBD 1.18
- TVTX 0.22
- Stochastic Oscillator
- BLBD 74.01
- TVTX 93.98
About BLBD Blue Bird Corporation
Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.